While men have had Viagra, Cialis, and Levitra to address their sexual dysfunction issues for about a decade, finding a solution for women’s woes has been more complicated. The market for female sexual dysfunction (FSD) drugs is believed larger than the market for male sexual dysfunction treatments, yet despite this no FDA-approved treatments for FSD exist—though several drug developers are closer than ever to changing that. Once approved, how much of a rise do you think they’ll get in sales compared to ED drugs?

Poll Question:
Do you think future FSD drugs have the potential to be as successful as ED drugs have been?



Previous articleTiGenix Steps Up Cell Therapy Effort
Next article15 Breast Cancer Drugs in the Pipeline Right Now